Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Marc Blaustein currently holds 27,995 shares of Finch Therapeutics Group, Inc. (FNCH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Blaustein has been a net seller of FNCH stock. They have purchased $0 and sold $6.8K worth of shares.
Marc Blaustein's most recent insider trade was on Feb 21, 2023, when they sold 4,619 shares at $0.38 per share.
Marc Blaustein serves as Executive at Finch Therapeutics Group, Inc. (FNCH). They have executed 3 insider transactions totaling $6.8K over their tenure at the company.
Marc Blaustein holds the position of Executive at Finch Therapeutics Group, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Marc Blaustein has shown a selling trading pattern, with $0 in total purchases and $6.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Marc Blaustein was on Oct 21, 2022, when they sold $5.1K worth of FNCH shares. This transaction involved 3,636 shares at $1.39 per share.
Marc Blaustein currently owns 27,995 shares of Finch Therapeutics Group, Inc. (FNCH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Marc Blaustein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Marc Blaustein has 3 Form 4 filings on record as an insider at Finch Therapeutics Group, Inc..
Set alerts for Marc Blaustein and 40,000+ other insiders.